{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:01:48Z","timestamp":1788188508975,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009409","name":"Russian Science Support Foundation","doi-asserted-by":"publisher","award":["21-15-00042"],"award-info":[{"award-number":["21-15-00042"]}],"id":[{"id":"10.13039\/100009409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.tube.2022.102168","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:35:45Z","timestamp":1642646145000},"page":"102168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mycobacterium abscessus drug discovery using machine learning"],"prefix":"10.1016","volume":"132","author":[{"given":"Alan A.","family":"Schmalstig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley M.","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Murcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Savina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5790","authenticated-orcid":false,"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2022.102168_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/med.21798","article-title":"Pipeline of anti-Mycobacterium abscessus small molecules: repurposable drugs and promising novel chemical entities","author":"Egorova","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.tube.2022.102168_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7030090","article-title":"Mycobacterium abscessus: environmental bacterium turned clinical nightmare","volume":"7","author":"Lopeman","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.tube.2022.102168_bib3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17460441.2019.1629414","article-title":"Repositioning rifamycins for Mycobacterium abscessus lung disease","volume":"14","author":"Ganapathy","year":"2019","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.tube.2022.102168_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/jac\/dkr154","article-title":"Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae","volume":"66","author":"Chopra","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib5","first-page":"61","article-title":"Rifabutin is active against Mycobacterium abscessus complex","author":"Aziz","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195595","article-title":"Pathogen Box screening for hit identification against Mycobacterium abscessus","volume":"13","author":"Jeong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102168_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3389\/fmicb.2017.01539","article-title":"Screening of TB actives for activity against nontuberculous mycobacteria delivers high hit rates","volume":"8","author":"Low","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2022.102168_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01008-19","article-title":"Extremely low hit rate in a diverse chemical drug screen targeting Mycobacterium abscessus","volume":"63","author":"Malin","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib9","first-page":"61","article-title":"Activity of LCB01-0371, a novel oxazolidinone, against Mycobacterium abscessus","author":"Kim","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib10","first-page":"21","article-title":"Etamycin as a novel Mycobacterium abscessus inhibitor","author":"Hanh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tube.2022.102168_bib11","first-page":"64","article-title":"TBAJ-876, a 3,5-dialkoxypyridine analogue of bedaquiline, is active against Mycobacterium abscessus","author":"Sarathy","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib12","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/j.bmcl.2018.08.026","article-title":"Discovery of benzothiazole amides as potent antimycobacterial agents","volume":"28","author":"Graham","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2022.102168_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/ijmy.ijmy_142_18","article-title":"Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus","volume":"7","author":"Kirkwood","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.tube.2022.102168_bib14","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3389\/fmicb.2017.02204","article-title":"Reporter-Based assays for high-throughput drug screening against Mycobacterium abscessus","volume":"8","author":"Gupta","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2022.102168_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00828-18","article-title":"Screening of preselected libraries targeting Mycobacterium abscessus for drug discovery","volume":"62","author":"Richter","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib16","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3389\/fmicb.2018.02417","article-title":"Novel screen to assess bactericidal activity of compounds against non-replicating Mycobacterium abscessus","volume":"9","author":"Berube","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2022.102168_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/mmi.13406","article-title":"A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus","volume":"101","author":"Dupont","year":"2016","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2022.102168_bib18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fmicb.2016.01392","article-title":"Fragment-Based whole cell screen delivers hits against M. tuberculosis and non-tuberculous mycobacteria","volume":"7","author":"Moreira","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tube.2022.102168_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063240","article-title":"Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian models","volume":"8","author":"Ekins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102168_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chembiol.2013.01.011","article-title":"Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery","volume":"20","author":"Ekins","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.tube.2022.102168_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tube.2013.12.001","article-title":"Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis","volume":"94","author":"Ekins","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2022.102168_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chembiol.2013.01.011","article-title":"Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery","volume":"20","author":"Ekins","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.tube.2022.102168_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11095-020-02876-y","article-title":"Machine learning platform to discover novel growth inhibitors of Neisseria gonorrhoeae","volume":"37","author":"Pereira","year":"2020","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.tube.2022.102168_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/c8mt00342d","article-title":"High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus","volume":"11","author":"Dalecki","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.tube.2022.102168_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13321-017-0220-4","article-title":"The Chemistry Development Kit (CDK) v2.0: atom typing, depiction, molecular formulas, and substructure searching","volume":"9","author":"Willighagen","year":"2017","journal-title":"J Cheminf"},{"key":"10.1016\/j.tube.2022.102168_bib26","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/acsomega.8b02948","article-title":"Ebola virus bayesian machine learning models enable new in vitro leads","volume":"4","author":"Anantpadma","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.tube.2022.102168_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11095-019-2671-y","article-title":"Repurposing approved drugs as inhibitors of Kv7.1 and Nav1.8 to treat pitt hopkins syndrome","volume":"36","author":"Ekins","year":"2019","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.tube.2022.102168_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","article-title":"Exploiting machine learning for end-to-end drug discovery and development","volume":"18","author":"Ekins","year":"2019","journal-title":"Nat Mater"},{"key":"10.1016\/j.tube.2022.102168_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-018-2558-3","article-title":"High throughput and computational repurposing for neglected diseases","volume":"36","author":"Hernandez","year":"2018","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.tube.2022.102168_bib30","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acs.molpharmaceut.8b00083","article-title":"Comparing and validating machine learning models for Mycobacterium tuberculosis drug discovery","volume":"15","author":"Lane","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tube.2022.102168_bib31","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1021\/acs.molpharmaceut.8b00546","article-title":"Comparing multiple machine learning algorithms and metrics for estrogen receptor binding prediction","volume":"15","author":"Russo","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tube.2022.102168_bib32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1124\/mol.117.111443","article-title":"Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates","volume":"94","author":"Sandoval","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.tube.2022.102168_bib33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acs.molpharmaceut.8b01214","article-title":"Halogen substitution influences ketamine metabolism by cytochrome P450 2B6: in vitro and computational approaches","volume":"16","author":"Wang","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tube.2022.102168_bib34","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.molpharmaceut.8b01297","article-title":"Multiple machine learning comparisons of HIV cell-based and reverse transcriptase data sets","volume":"16","author":"Zorn","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tube.2022.102168_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1021\/acs.jcim.5b00143","article-title":"Open source bayesian models. 1. Application to ADME\/tox and drug discovery datasets","volume":"55","author":"Clark","year":"2015","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.tube.2022.102168_bib36","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.01551-06","article-title":"In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan","volume":"51","author":"Shen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib37","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1021\/acs.jmedchem.7b00582","article-title":"Targeting mycolic acid transport by indole-2-carboxamides for the treatment of Mycobacterium abscessus infections","volume":"60","author":"Kozikowski","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2022.102168_bib38","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.bmc.2017.05.015","article-title":"Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity","volume":"25","author":"Franz","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2022.102168_bib39","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/AAC.00695-08","article-title":"In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria","volume":"52","author":"Fernandez-Roblas","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tube.2011.12.002","article-title":"Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria","volume":"92","author":"Falkinham","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2022.102168_bib41","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/AAC.01545-09","article-title":"In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species","volume":"54","author":"Disratthakit","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2022.102168_bib42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejmech.2015.07.001","article-title":"Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates","volume":"101","author":"Baranyai","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2022.102168_bib43","first-page":"15423","article-title":"In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents","volume":"8","author":"Pang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.tube.2022.102168_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1573406410666150807111703","article-title":"Investigation of the antimycobacterial activity of 8-hydroxyquinolines","volume":"11","author":"Cieslik","year":"2015","journal-title":"Med Chem"},{"key":"10.1016\/j.tube.2022.102168_bib45","series-title":"Opportunistic infection and tuberculosis Therapeutics database","author":"Anon","year":"2018"},{"key":"10.1016\/j.tube.2022.102168_bib46","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tube.2022.102168_bib47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/b917766c","article-title":"A collaborative database and computational models for tuberculosis drug discovery","volume":"6","author":"Ekins","year":"2010","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.tube.2022.102168_bib48","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1039\/C0MB00104J","article-title":"Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis","volume":"6","author":"Ekins","year":"2010","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.tube.2022.102168_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tube.2022.102168_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063240","article-title":"Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event bayesian models","volume":"8","author":"Ekins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2022.102168_bib51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tube.2013.12.001","article-title":"Bayesian models for screening and TB mobile for target inference with Mycobacterium tuberculosis","volume":"94","author":"Ekins","year":"2014","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.tube.2022.102168_bib52","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/ci400480s","article-title":"Fusing dual-event datasets for Mycobacterium Tuberculosis machine learning models and their evaluation","volume":"53","author":"Ekins","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.tube.2022.102168_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11095-013-1172-7","article-title":"Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discovery","volume":"31","author":"Ekins","year":"2014","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.tube.2022.102168_bib54","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/ci500264r","article-title":"Are bigger data sets better for machine learning? Fusing single-point and dual-event dose response data for Mycobacterium tuberculosis","volume":"54","author":"Ekins","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.tube.2022.102168_bib55","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.jcim.6b00004","article-title":"Machine learning model analysis and data visualization with small molecules tested in a mouse model of Mycobacterium tuberculosis infection (2014-2015)","volume":"56","author":"Ekins","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.tube.2022.102168_bib56","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1021\/ci500077v","article-title":"Looking back to the future: predicting in vivo efficacy of small molecules versus Mycobacterium tuberculosis","volume":"54","author":"Ekins","year":"2014","journal-title":"J Chem Inf Model"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979222000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979222000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:46:27Z","timestamp":1761468387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979222000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":56,"alternative-id":["S1472979222000051"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2022.102168","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium abscessus drug discovery using machine learning","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2022.102168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102168"}}